196 related articles for article (PubMed ID: 19626588)
1. Synergistic actions of atorvastatin with gamma-tocotrienol and celecoxib against human colon cancer HT29 and HCT116 cells.
Yang Z; Xiao H; Jin H; Koo PT; Tsang DJ; Yang CS
Int J Cancer; 2010 Feb; 126(4):852-63. PubMed ID: 19626588
[TBL] [Abstract][Full Text] [Related]
2. Combination of atorvastatin and celecoxib synergistically induces cell cycle arrest and apoptosis in colon cancer cells.
Xiao H; Zhang Q; Lin Y; Reddy BS; Yang CS
Int J Cancer; 2008 May; 122(9):2115-24. PubMed ID: 18172863
[TBL] [Abstract][Full Text] [Related]
3. Regulation of macrophage cholesterol efflux through hydroxymethylglutaryl-CoA reductase inhibition: a role for RhoA in ABCA1-mediated cholesterol efflux.
Argmann CA; Edwards JY; Sawyez CG; O'Neil CH; Hegele RA; Pickering JG; Huff MW
J Biol Chem; 2005 Jun; 280(23):22212-21. PubMed ID: 15817453
[TBL] [Abstract][Full Text] [Related]
4. A metabolite of nobiletin, 4'-demethylnobiletin and atorvastatin synergistically inhibits human colon cancer cell growth by inducing G0/G1 cell cycle arrest and apoptosis.
Wu X; Song M; Qiu P; Li F; Wang M; Zheng J; Wang Q; Xu F; Xiao H
Food Funct; 2018 Jan; 9(1):87-95. PubMed ID: 29063088
[TBL] [Abstract][Full Text] [Related]
5. Synergistic chemopreventive effects of nobiletin and atorvastatin on colon carcinogenesis.
Wu X; Song M; Qiu P; Rakariyatham K; Li F; Gao Z; Cai X; Wang M; Xu F; Zheng J; Xiao H
Carcinogenesis; 2017 Apr; 38(4):455-464. PubMed ID: 28207072
[TBL] [Abstract][Full Text] [Related]
6. Gamma-tocotrienol reverses multidrug resistance of breast cancer cells with a mechanism distinct from that of atorvastatin.
Ding Y; Peng Y; Deng L; Fan J; Huang B
J Steroid Biochem Mol Biol; 2017 Mar; 167():67-77. PubMed ID: 27864002
[TBL] [Abstract][Full Text] [Related]
7. Atorvastatin and celecoxib inhibit prostate PC-3 tumors in immunodeficient mice.
Zheng X; Cui XX; Avila GE; Huang MT; Liu Y; Patel J; Kong AN; Paulino R; Shih WJ; Lin Y; Rabson AB; Reddy BS; Conney AH
Clin Cancer Res; 2007 Sep; 13(18 Pt 1):5480-7. PubMed ID: 17875778
[TBL] [Abstract][Full Text] [Related]
8. Celecoxib but not the combination of celecoxib+atorvastatin prevents the development of monocrotaline-induced pulmonary hypertension in the rat.
Rakotoniaina Z; Guerard P; Lirussi F; Rochette L; Dumas M; Goirand F; Bardou M
Naunyn Schmiedebergs Arch Pharmacol; 2008 Sep; 378(3):241-51. PubMed ID: 18542928
[TBL] [Abstract][Full Text] [Related]
9. HMG-CoA reductase regulates CCL17-induced colon cancer cell migration via geranylgeranylation and RhoA activation.
Al-Haidari AA; Syk I; Thorlacius H
Biochem Biophys Res Commun; 2014 Mar; 446(1):68-72. PubMed ID: 24582560
[TBL] [Abstract][Full Text] [Related]
10. Synergistic effect of combined treatment with gamma-tocotrienol and statin on human malignant mesothelioma cells.
Tuerdi G; Ichinomiya S; Sato H; Siddig S; Suwa E; Iwata H; Yano T; Ueno K
Cancer Lett; 2013 Oct; 339(1):116-27. PubMed ID: 23879968
[TBL] [Abstract][Full Text] [Related]
11. Studies of the isoprenoid-mediated inhibition of mevalonate synthesis applied to cancer chemotherapy and chemoprevention.
Mo H; Elson CE
Exp Biol Med (Maywood); 2004 Jul; 229(7):567-85. PubMed ID: 15229351
[TBL] [Abstract][Full Text] [Related]
12. γ-Tocotrienol protects against ovariectomy-induced bone loss via mevalonate pathway as HMG-CoA reductase inhibitor.
Deng L; Ding Y; Peng Y; Wu Y; Fan J; Li W; Yang R; Yang M; Fu Q
Bone; 2014 Oct; 67():200-7. PubMed ID: 25019595
[TBL] [Abstract][Full Text] [Related]
13. Statins inhibit blastocyst formation by preventing geranylgeranylation.
Alarcon VB; Marikawa Y
Mol Hum Reprod; 2016 May; 22(5):350-63. PubMed ID: 26908642
[TBL] [Abstract][Full Text] [Related]
14. Metabolism of tocotrienols in animals and synergistic inhibitory actions of tocotrienols with atorvastatin in cancer cells.
Yang Z; Lee MJ; Zhao Y; Yang CS
Genes Nutr; 2012 Jan; 7(1):11-8. PubMed ID: 21590436
[TBL] [Abstract][Full Text] [Related]
15. Suppression in mevalonate synthesis mediates antitumor effects of combined statin and gamma-tocotrienol treatment.
Wali VB; Bachawal SV; Sylvester PW
Lipids; 2009 Oct; 44(10):925-34. PubMed ID: 19777282
[TBL] [Abstract][Full Text] [Related]
16. Synergistic anticancer effects of combined gamma-tocotrienol and celecoxib treatment are associated with suppression in Akt and NFkappaB signaling.
Shirode AB; Sylvester PW
Biomed Pharmacother; 2010 May; 64(5):327-32. PubMed ID: 19954924
[TBL] [Abstract][Full Text] [Related]
17. Synergistic Effect of Tangeretin and Atorvastatin for Colon Cancer Combination Therapy: Targeted Delivery of These Dual Drugs Using RGD Peptide Decorated Nanocarriers.
Bao H; Zheng N; Li Z; Zhi Y
Drug Des Devel Ther; 2020; 14():3057-3068. PubMed ID: 32801644
[TBL] [Abstract][Full Text] [Related]
18. Atorvastatin induces apoptosis in vitro and slows growth of tumor xenografts but not polyp formation in MIN mice.
Huang EH; Johnson LA; Eaton K; Hynes MJ; Carpentino JE; Higgins PD
Dig Dis Sci; 2010 Nov; 55(11):3086-94. PubMed ID: 20186482
[TBL] [Abstract][Full Text] [Related]
19. Synergistic inhibition of colon cancer cell growth by a combination of atorvastatin and phloretin.
Zhou M; Zheng J; Bi J; Wu X; Lyu J; Gao K
Oncol Lett; 2018 Feb; 15(2):1985-1992. PubMed ID: 29399200
[TBL] [Abstract][Full Text] [Related]
20. A triple combination of atorvastatin, celecoxib and tipifarnib strongly inhibits pancreatic cancer cells and xenograft pancreatic tumors.
Ding N; Cui XX; Gao Z; Huang H; Wei X; Du Z; Lin Y; Shih WJ; Rabson AB; Conney AH; Hu C; Zheng X
Int J Oncol; 2014 Jun; 44(6):2139-45. PubMed ID: 24647860
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
